Our News on Newswise

Newswise: HafftyBruce_2.jpg

Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor of Cancer Programs Receives Prestigious National Award

Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been selected as the 2020 Gold Medal Award winner by the American Society for Radiation Oncology (ASTRO),...
27-May-2020 12:25 PM EDT Add to Favorites

Are there any Programs for Quitting Tobacco?

For this 2020 World No Tobacco Day, experts from the Rutgers Tobacco Dependence Program discuss New Jersey quit centers and how quitting tobacco can benefit one during cancer treatment.
19-May-2020 10:05 AM EDT Add to Favorites

Newswise: Herranz_Benito_DanielSH19.jpg

Exploring Treatment Strategies in T-cell Acute Lymphoblastic Leukemia

Researchers from Rutgers Cancer Institute of New Jersey along with collaborators from Princeton University identify a new drug that has therapeutic effect against the aggressive hematological disease T-cell acute lymphoblastic leukemia.
12-May-2020 10:50 AM EDT Add to Favorites

Newswise: MehnertJ_coatDVogel0314.jpg

Superior Progression-Free Survival Associated with Continuous Targeted Therapy Combination for BRAF-mutated Melanoma

Results from a randomized phase 2 clinical trial examining the targeted therapy drugs dabrafenib and tremetinib in both continuous and intermittent treatment of patients with BRAF-mutated melanoma show continuous dosing yields superior progression...
27-Apr-2020 9:00 AM EDT Add to Favorites

Newswise: librarylasin.jpg

Finding Credible Cancer Education Resources during the COVID-19 Pandemic

While most public, hospital and academic libraries are closed to visitors due to the COVID-19 pandemic, there is a wealth of information available online, especially for cancer patients seeking disease specific information. Rutgers Cancer Institute...
15-Apr-2020 8:50 AM EDT Add to Favorites

Newswise: dishes-iStock-168490576.jpg

Rutgers Cancer Institute Offers Clinical Trial Examining Potential Treatment for COVID-19

Rutgers Cancer Institute of New Jersey, a National Cancer Institute-designated Comprehensive Cancer Center, is offering a clinical trial as a potential treatment for patients diagnosed with the coronavirus (COVID-19). The trial, which is not limited...
3-Apr-2020 1:35 PM EDT Add to Favorites

Newswise: White-RutgersCancer101.JPG

Rutgers Cancer Institute of New Jersey Research Shows Autophagy Impacts Stress Response Pathways Promoting Survival in Laboratory Models

Research from investigators at Rutgers Cancer Institute of New Jersey shows that a cellular process known as autophagy promotes survival in mouse models by suppressing oxidative stress and a tumor suppressor known as p53.
18-Mar-2020 4:00 PM EDT Add to Favorites

Newswise: Jabbour-RutgersCancer392.JPG

Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Safe and Tolerable as First-Line Therapy

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for...
18-Feb-2020 4:05 PM EST Add to Favorites

See All News

Our Experts on Newswise

Newswise: IMG_2298PREFERRED.jpg

Oncology Pharmacists: An Essential Partner in the Cancer Journey

One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey...
18-Oct-2019 8:00 AM EDT

Newswise: shicha-kumar.png

Lumpectomy for Breast Cancer with Attention to Cosmetic Results

As more women live with breast cancer, minimization of significant deformity in the breast after breast preservation is increasingly gaining attention. A Rutgers Cancer Institute of New Jersey surgical oncologist shares some insight.
25-Sep-2019 2:05 PM EDT

Newswise: Kritharis_Athena_1_SP2018.jpg

Leukemia: Not Just One Disease

An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults.
30-Aug-2019 8:05 AM EDT

Newswise: screening50scouplewdocrelease.jpg

Colorectal Cancer: Advancing Awareness

Colorectal cancer is the third leading cancer in both new cases and cancer deaths in the United States. While colorectal cancer incidence declined 3.7 percent annually from 2006 to 2015 for those 55 and older, rates have increased 1.8 percent...
18-Mar-2019 3:05 PM EDT

Newswise: lungartredshutterstock_5325632082.jpg

A New Tool to Help Fight an Old Enemy – Lung Cancer

In the U.S., lung cancer remains the leading cause of cancer death among both men and women. The primary reason for high death rates for lung cancer is the fact that this disease is typically detected in very late stages. A Rutgers University expert...
30-Oct-2018 5:05 PM EDT

Newswise: sicklecell18card-1-L.jpg

September is Sickle Cell Disease Awareness Month

Sickle cell disease is a common inherited blood disorder, affecting an estimated 100,000 Americans of different racial and ethnic groups. A Rutgers Cancer Institute of New Jersey expert shares more about the importance of early diagnosis and...
24-Sep-2018 8:00 AM EDT

Newswise: thyroidpuzzleshutterstock_342277517.jpg

Thyroid Cancer 101

While thyroid cancers are common, they may not be as widely understood as other common cancers such as breast or prostate. A Rutgers Cancer Institute of New Jersey expert shares more about the butterfly-shaped gland in the lower neck and how...
18-Sep-2018 8:00 AM EDT

Newswise: womenmulticulturalshutterstock_583329955.jpg

Ovarian Cancer: What You Need to Know

During this Gynecologic Cancers Awareness Month, a Rutgers Cancer Institute of New Jersey expert shares info on symptoms and treatment of ovarian cancer.
14-Sep-2018 12:00 PM EDT

See All Experts

Our YouTube Videos


As New Jersey’s only National Cancer Institute (NCI) – designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey’s team of internationally recognized physicians and researchers is driven by a singular focus and mission, to help individuals fight cancer. Through the transformation of laboratory discoveries into clinical practice, we target cancer with precision medicine, immunotherapy and clinical trials and provide the most advanced, comprehensive, and compassionate world-class cancer care to adults and children. This mission is being accomplished in partnership with RWJBarnabas Health. Rutgers Cancer Institute physicians and scientists work side by side to make sure the most sophisticated treatments are delivered to our patients quickly and safely - the future of cancer treatments today.

The coveted NCI Comprehensive Cancer Center designation, awarded to only an elite group of such centers nationwide, is granted competitively to institutions characterized by their scientific leadership, resources, and the depth and breadth of an outstanding track record of research discoveries in basic, clinical, and population science as well as the ability to translate these discoveries to benefit cancer patients. To gain a Comprehensive Cancer Center designation, the highest ranking given by the NCI, a center must meet rigorous criteria in cancer care, research, prevention and education and demonstrate an added depth and breadth of research, as well as substantial transdisciplinary research that bridges these scientific areas. Rutgers Cancer Institute operates as a consortium cancer center between Rutgers University, Princeton University, and the Institute for Advanced Study in Princeton, as identified by the NCI. Rutgers Cancer Institute brings together the top cancer researchers and clinicians throughout New Jersey to apply the latest technologies, therapies, and approaches to improve cancer diagnosis, treatment, and prevention.



Main Box
Program Assistant



Krista Didzbalis
Media Relations Assistant


Michele Fisher
Associate Director, Marketing & Communications